NasdaqGM - Nasdaq Real Time Price USD

Orchestra BioMed Holdings, Inc. (OBIO)

2.8200
-0.1200
(-4.08%)
At close: May 14 at 4:00:00 PM EDT
All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-50,558
-50,558
-46,127
-29,289
-19,429
Investing Cash Flow
13,089
13,089
10,687
-64,122
13,017
Financing Cash Flow
29,171
29,171
46,215
103,257
-3,993
End Cash Position
22,261
22,261
30,559
19,784
9,938
Interest Paid Supplemental Data
102
102
1,119
1,371
389
Capital Expenditure
-289
-289
-78
-591
-274
Issuance of Capital Stock
15,035
15,035
0
109,830
--
Issuance of Debt
15,000
15,000
0
10,000
0
Repayment of Debt
0
0
-10,849
-6,446
-4,000
Free Cash Flow
-50,847
-50,847
-46,205
-29,880
-19,703
12/31/2021 - 8/4/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ACRV Acrivon Therapeutics, Inc.
1.1400
+0.88%
 
RZLT Rezolute, Inc.
3.4900
-4.90%
 
LXEO Lexeo Therapeutics, Inc.
2.6900
-4.95%
 
PCSA Processa Pharmaceuticals, Inc.
0.2340
+2.09%
 
JBIO Jade Biosciences, Inc.
7.55
-12.31%
 
VRDN Viridian Therapeutics, Inc.
12.38
-3.36%
 
MTNB Matinas BioPharma Holdings, Inc.
0.6877
+5.27%
 
INZY Inozyme Pharma, Inc.
1.3500
+23.85%
 
ADVM Adverum Biotechnologies, Inc.
2.0600
-7.00%
 
ABEO Abeona Therapeutics Inc.
5.39
-4.26%